Transformative Diagnostics



Next-Generation Therapies & Vaccines

Addressing large, unmet global markets with innovative proprietary products More »


Worldwide Production & Distribution

Capitalizing on high-value, emerging markets for pharmaceutical and diagnostic products More »


Strategic Investments

Identifying early-stage companies with potential to increase value for shareholders More »

Chairman’s Message

OPKO continues to make progress with its program to build a company capable of long-term growth and increasing value to its investors and I would like to review several highlights.



 OPKO Completes Acquisition of Bio-Reference Laboratories.



OPKO Letter to Shareholders»

News & Events

more news »

Conversion Right Extended on OPKO 3.0% Convertible Senior Notes more »

OPKO Health to Present at the Ladenburg Thalmann 2015 Healthcare Conference more »

OPKO Health Announces Global License Agreement for the Discovery of Novel Antimicrobials more »


read more »

OPKO Health is an opportunistic research and development company that targets large, high-growth markets.



Former shareholders of Bio-Reference Laboratories, Inc. that have questions related to the exchange of BRLI shares to OPK shares, please contact our exchange agent, American Stock Transfer & Trust Company, LLC, toll free at (877) 248-6417 or (718) 921-8317.